{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:47:00Z","timestamp":1783352820681,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"am","delay-in-days":435,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beha.2025.101596","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:52:01Z","timestamp":1738889521000},"page":"101596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analyte heterogeneity analysis as a possible potency parameter for MSC"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7069-9254","authenticated-orcid":false,"given":"David","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Planchon","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2025.101596_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.blre.2018.11.001","article-title":"Allogeneic hematopoietic cell transplantation; the current renaissance","volume":"34","author":"Copelan","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.beha.2025.101596_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations, and management","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.beha.2025.101596_bib3","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2025.101596_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jor.23560","article-title":"New MSC: MSC's as pericytes are sentinels and gatekeepers","volume":"35","author":"Caplan","year":"2017","journal-title":"J Orthop Res"},{"key":"10.1016\/j.beha.2025.101596_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.imlet.2015.06.005","article-title":"The MSC curtain that stops the immune system","volume":"168","author":"Caplan","year":"2015","journal-title":"Immunol Lett"},{"key":"10.1016\/j.beha.2025.101596_bib6","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/trf.15252","article-title":"Production and quality testing of multipotent mesenchymal stromal cell therapeutics for clinical use","volume":"59","author":"Bieback","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.beha.2025.101596_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2010.02.005","article-title":"Mesenchymal stem cell therapy: two steps forward, one step back","volume":"16","author":"Ankrum","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.beha.2025.101596_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2022.12.001","article-title":"A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis","volume":"22","author":"Roesch","year":"2023","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.beha.2025.101596_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00458","article-title":"Human mesenchymal stromal cell (MSC) characteristics vary among laboratories when manufactured from the same source material: a report by the cellular therapy team of the biomedical excellence for safer transfusion (BEST) collaborative","author":"Stroncek","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.beha.2025.101596_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12967-024-05294-5","article-title":"Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.beha.2025.101596_bib11","article-title":"Cell-type specific molecular expression levels by restricted-dimensional cytometry","volume":"54","author":"Kaplan","year":"2024","journal-title":"rdC. European J Clin Invest"},{"key":"10.1016\/j.beha.2025.101596_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1097-0320(20000501)40:1<81::AID-CYTO11>3.0.CO;2-K","article-title":"Enzymatic amplification staining for flow cytometric analysis of cell surface molecules","volume":"40","author":"Kaplan","year":"2000","journal-title":"Cytometry"},{"key":"10.1016\/j.beha.2025.101596_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/KXQ7-LHKC-CYQ8-R70W","article-title":"High resolution immunophenotypic analysis of chronic lymphocytic leukemia cells by enzymatic amplification staining (EAS)","volume":"116","author":"Kaplan","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2025.101596_bib14","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1073\/pnas.241509398","article-title":"CD5 expression by B lymphocytes and its regulation upon Epstein-Barr Virus transformation","volume":"98","author":"Kaplan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2025.101596_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/0953710031000080577","article-title":"CD34 expression on platelets","volume":"14","author":"Kaplan","year":"2003","journal-title":"Platelets"},{"key":"10.1016\/j.beha.2025.101596_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.a.20103","article-title":"D cyclins in lymphocytes","volume":"63A","author":"Kaplan","year":"2005","journal-title":"Cytometry"},{"key":"10.1016\/j.beha.2025.101596_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1309\/7C2VV961P60RMLHD","article-title":"D cyclins in CD5+ B cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia","volume":"125","author":"Meyerson","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2025.101596_bib18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bbmt.2011.03.005","article-title":"Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts","volume":"17","author":"Lazarus","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2025.101596_bib19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/cyto.a.22485","article-title":"Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70","volume":"85A","author":"Kaplan","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.beha.2025.101596_bib20","doi-asserted-by":"crossref","first-page":"E228","DOI":"10.1002\/ajh.23832","article-title":"Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia","volume":"89","author":"Mitchell","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2025.101596_bib21","first-page":"8","article-title":"Protein biomarkers in monocytes and CD4+ lymphocytes for predicting lithium treatment response of bipolar disorder: a feasibility study with tyramine-based signal-amplified flow cytometry","volume":"52","author":"Gao","year":"2022","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.beha.2025.101596_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59010120","article-title":"Divergent directionality of immune cell-specific protein expression between bipolar lithium responders and non-responders revealed by enhanced flow cytometry","volume":"59","author":"Gao","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.beha.2025.101596_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2023.02.058","article-title":"Differences in intracellular protein levels in monocytes and CD4+ lymphocytes between bipolar depressed patients and healthy controls: a pilot study with tyramine-based signal-amplified flow cytometry","volume":"328","author":"Gao","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.beha.2025.101596_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1352458517703802","article-title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","volume":"24","author":"Cohen","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.beha.2025.101596_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.22065","article-title":"Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: implication for multiple sclerosis","volume":"68","author":"Darlington","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.beha.2025.101596_bib26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/cea.12165","article-title":"Activation of TLR4 induces VEGF expression via Akt pathway in nasal polyps","volume":"43","author":"Cho","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.beha.2025.101596_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15046","article-title":"Direct inhibition of the TLR4\/MyD88 pathway by geniposide suppresses HIF-1a-independent VEGF expression and angiogenesis in hepatocellular carcinoma","author":"Zhang","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.beha.2025.101596_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21873\/cgp.20145","article-title":"MyD88 regulates LPS-induced NF-kB\/MAPK cytokines and promotes inflammation and malignancy in colorectal cancer cells","volume":"16","author":"Zhu","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.beha.2025.101596_bib29","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2353\/ajpath.2007.061048","article-title":"Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors","volume":"171","author":"Macedo","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2025.101596_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3727\/096368913X675142","article-title":"Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts","volume":"24","author":"Oliveira","year":"2015","journal-title":"Cell Transplant"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692625000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692625000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:22:34Z","timestamp":1741609354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692625000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521692625000015"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2025.101596","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyte heterogeneity analysis as a possible potency parameter for MSC","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2025.101596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101596"}}